{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:50:23Z","timestamp":1762530623105,"version":"build-2065373602"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.adro.2023.101367","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T03:22:00Z","timestamp":1693538520000},"page":"101367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC) With Single Photon Emission Computed Tomography (SPECT) Functional Treatment Planning in Patients With Advanced Hepatic Cirrhosis"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6457-1190","authenticated-orcid":false,"given":"Alexander","family":"Kirichenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahiro","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaakir","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Abel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Renz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parisa","family":"Shamsesfandabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngoc","family":"Thai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2023.101367_bib0001","first-page":"317","article-title":"Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: An analysis of SEER-Medicare","volume":"32","author":"Zhang","year":"2021","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.adro.2023.101367_bib0002","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"issue":"Suppl","key":"10.1016\/j.adro.2023.101367_bib0003","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/MCG.0b013e318286ff8e","article-title":"Liver transplantation for hepatocellular carcinoma: A surgical perspective","volume":"47","author":"Fortune","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.adro.2023.101367_bib0004","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jncc.2022.05.002","article-title":"The role of stereotactic body radiotherapy in hepatocellular carcinoma: Guidelines and evidences","volume":"2","author":"Hu","year":"2022","journal-title":"J Natl Cancer Center"},{"key":"10.1016\/j.adro.2023.101367_bib0005","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4240\/wjgs.v9.i12.256","article-title":"Hepatocellular carcinoma with Child Pugh-A cirrhosis treated with stereotactic body radiotherapy","volume":"9","author":"Hasan","year":"2017","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.adro.2023.101367_bib0006","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s13566-017-0325-4","article-title":"Liver stereotactic radiotherapy (SRT) with functional treatment planning for patients with intermediate stage hepatocellular carcinoma (HCC)","volume":"6","author":"Kudithipudi","year":"2017","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101367_bib0007","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.hpb.2015.07.007","article-title":"Stereotactic body radiotherapy (SBRT) with or without surgery for primary and metastatic liver tumors","volume":"18","author":"Kirichenko","year":"2016","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.adro.2023.101367_bib0008","doi-asserted-by":"crossref","first-page":"261","DOI":"10.14694\/EdBook_AM.2012.32.171","article-title":"Stereotactic body radiation therapy for hepatocellular carcinoma","author":"Dawson","year":"2012","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.adro.2023.101367_bib0009","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00268-018-4829-x","article-title":"Stereotactic body radiation therapy: A new strategy for loco-regional treatment for hepatocellular carcinoma while awaiting liver transplantation","volume":"43","author":"Uemura","year":"2019","journal-title":"World J Surg"},{"key":"10.1016\/j.adro.2023.101367_bib0010","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijrobp.2011.08.032","article-title":"Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: Clinical outcome and pathologic correlation","volume":"83","author":"Katz","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101367_bib0011","article-title":"Outcomes after stereotactic body radiation therapy as a bridging modality to liver transplantation for hepatocellular carcinoma","volume":"6","author":"Garg","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101367_bib0012","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.radonc.2008.11.002","article-title":"Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis","volume":"92","author":"Meng","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2023.101367_bib0013","first-page":"261","article-title":"Stereotactic body radiotherapy used as a bridge to liver transplant in patients with hepatocellular carcinoma and Child-Pugh score \u22658 cirrhosis","volume":"5","author":"Gresswell","year":"2018","journal-title":"J Radiosurg SBRT"},{"key":"10.1016\/j.adro.2023.101367_bib0014","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2004.05.048","article-title":"Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease","volume":"60","author":"Cheng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101367_bib0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.prro.2014.09.007","article-title":"Effect of high-dose stereotactic body radiation therapy on liver function in the treatment of primary and metastatic liver malignancies using the Child-Pugh score classification system","volume":"5","author":"Dyk","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101367_bib0016","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.semradonc.2018.06.007","article-title":"Radiation-induced liver disease and modern radiotherapy","volume":"28","author":"Koay","year":"2018","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101367_bib0017","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1748-717X-8-249","article-title":"Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: Clinical and dose-volumetric parameters","volume":"8","author":"Jung","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101367_bib0018","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ijrobp.2017.01.221","article-title":"Predictors of liver toxicity following stereotactic body radiation therapy for hepatocellular carcinoma","volume":"97","author":"Velec","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101367_bib0019","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/0284186X.2013.820342","article-title":"Stereotactic body radiotherapy for small hepatocellular carcinoma: A retrospective outcome analysis in 185 patients","volume":"53","author":"Sanuki","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.adro.2023.101367_bib0020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2014.05.002","article-title":"Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma","volume":"111","author":"Culleton","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2023.101367_bib0021","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1016\/j.prro.2015.02.007","article-title":"Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy","volume":"5","author":"Lasley","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101367_bib0022","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/hepr.12383","article-title":"Influence of liver toxicities on prognosis after stereotactic body radiation therapy for hepatocellular carcinoma","volume":"45","author":"Sanuki","year":"2015","journal-title":"Hepatol Res"},{"key":"10.1016\/j.adro.2023.101367_bib0023","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.ijrobp.2018.08.029","article-title":"Functional liver imaging and dosimetry to predict hepatotoxicity risk in cirrhotic patients with primary liver cancer","volume":"102","author":"Schaub","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101367_bib0024","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.prro.2017.10.013","article-title":"Toward consensus reporting of radiation-induced liver toxicity in the treatment of primary liver malignancies: Defining clinically relevant endpoints","volume":"8","author":"Chapman","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101367_bib0025","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.adro.2020.01.009","article-title":"Stereotactic body radiation therapy for hepatocellular carcinoma in patients with Child-Pugh B or C cirrhosis","volume":"5","author":"Lee","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101367_bib0026","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2217\/pme.10.5","article-title":"Adaptive trial of personalized radiotherapy for intrahepatic cancer","volume":"7","author":"Normolle","year":"2010","journal-title":"Per Med"},{"key":"10.1016\/j.adro.2023.101367_bib0027","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jamaoncol.2017.2303","article-title":"Individualized adaptive stereotactic body radiotherapy for liver tumors in patients at high risk for liver damage: A phase 2 clinical trial","volume":"4","author":"Feng","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.adro.2023.101367_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115667","article-title":"DCE-MRI of the liver: Reconstruction of the arterial input function using a low dose pre-bolus contrast injection","volume":"9","author":"Jajamovich","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.adro.2023.101367_bib0029","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.meddos.2017.01.005","article-title":"Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma","volume":"42","author":"Tsegmed","year":"2017","journal-title":"Med Dosim"},{"key":"10.1016\/j.adro.2023.101367_bib0030","first-page":"1511","article-title":"Dose-function histogram evaluation using (99m)Tc-GSA SPECT\/CT images for stereotactic body radiation therapy planning for hepatocellular carcinoma patients: A dosimetric parameter comparison","volume":"38","author":"Toya","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.adro.2023.101367_bib0031","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.surg.2016.02.009","article-title":"Liver function assessment using 99mTc-GSA single-photon emission computed tomography (SPECT)\/CT fusion imaging in hilar bile duct cancer: A retrospective study","volume":"160","author":"Sumiyoshi","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.adro.2023.101367_bib0032","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.acra.2014.11.006","article-title":"Assessment of liver function and liver fibrosis with dynamic Gd-EOB-DTPA-enhanced MRI","volume":"22","author":"Xie","year":"2015","journal-title":"Acad Radiol"},{"key":"10.1016\/j.adro.2023.101367_bib0033","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.meddos.2019.07.007","article-title":"Functional liver-image guided hepatic therapy (FLIGHT): A technique to maximize hepatic functional reserve","volume":"45","author":"Furukawa","year":"2020","journal-title":"Med Dosim"},{"key":"10.1016\/j.adro.2023.101367_bib0034","first-page":"2054","article-title":"Functional measurement of nonfibrotic hepatic mass in cirrhotic patients","volume":"92","author":"Hoefs","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.adro.2023.101367_bib0035","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0168-8278(03)00296-4","article-title":"Quantitative liver-spleen scan using single-photon emission computerized tomography (SPECT) for assessment of hepatic function in cirrhotic patients","volume":"39","author":"Zuckerman","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.adro.2023.101367_bib0036","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.ijrobp.2018.06.017","article-title":"Regional radiation dose-response modeling of functional liver in hepatocellular carcinoma patients with longitudinal sulfur colloid SPECT\/CT: A proof of concept","volume":"102","author":"Price","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101367_bib0037","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.1118\/1.4766877","article-title":"A method for registration of single-photon emission computed tomography (SPECT) and computed tomography (CT) images for liver stereotactic radiotherapy (SRT)","volume":"39","author":"Gayou","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.adro.2023.101367_bib0038","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.1840210515","article-title":"Calculation of child and adult standard liver volume for liver transplantation","volume":"21","author":"Urata","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.adro.2023.101367_bib0039","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijrobp.2006.11.060","article-title":"Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the radioembolization brachytherapy oncology consortium","volume":"68","author":"Kennedy","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101367_bib0040","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0360-3016(87)90045-9","article-title":"A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: Results of a Radiation Therapy Oncology Group randomized prospective trial","volume":"13","author":"Leibel","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101367_bib0041","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0360-3016(93)90428-X","article-title":"Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: Results of the RTOG dose escalating protocol","volume":"27","author":"Russell","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101367_bib0042","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canrad.2007.12.007","article-title":"The evolving role of radiation therapy in hepatocellular carcinoma","volume":"12","author":"Dawson","year":"2008","journal-title":"Cancer Radiother"},{"issue":"2","key":"10.1016\/j.adro.2023.101367_bib0043","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.adro.2023.101367_bib0044","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jhep.2005.01.019","article-title":"Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score","volume":"42","author":"Huo","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.adro.2023.101367_bib0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3350\/cmh.2013.19.2.105","article-title":"Important predictor of mortality in patients with end-stage liver disease","volume":"19","author":"Kim","year":"2013","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.adro.2023.101367_bib0046","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.diii.2019.05.006","article-title":"Intra arterial treatment of hepatocellular carcinoma: Comparison of MELD score variations between radio-embolization and chemo-embolization","volume":"100","author":"Delicque","year":"2019","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.adro.2023.101367_bib0047","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0168-8278(01)00309-9","article-title":"MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt","volume":"36","author":"Salerno","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.adro.2023.101367_bib0048","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101367_bib0049","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s13566-018-0354-7","article-title":"The albumin-bilirubin (ALBI) model in hepatocellular carcinoma (HCC) may better predict hepatic failure in patients with traditionally low-risk cirrhosis following definitive stereotactic body radiotherapy (SBRT)","volume":"7","author":"Hasan","year":"2018","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101367_bib0050","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0360-3016(92)90651-W","article-title":"The use of 3-D dose volume analysis to predict radiation hepatitis","volume":"23","author":"Lawrence","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101367_bib0051","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijrobp.2005.12.031","article-title":"Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance","volume":"65","author":"Liang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101367_bib0052","first-page":"16","article-title":"Significance of (99m)Tc-GSA liver scintigraphy in liver surgery and transplantation","volume":"3","author":"Iida","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.adro.2023.101367_bib0053","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ijrobp.2009.03.023","article-title":"Feasibility and efficacy of single-photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma 8 cm or more with portal vein tumor thrombus in combination with transcatheter arterial chemoembolization","volume":"76","author":"Shirai","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101367_bib0054","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.04.055","article-title":"Single-photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus","volume":"73","author":"Shirai","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101367_bib0055","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/15384101.2022.2131163","article-title":"Radiation-induced liver disease: Beyond DNA damage","volume":"22","author":"Zhou","year":"2023","journal-title":"Cell Cycle"},{"key":"10.1016\/j.adro.2023.101367_bib0056","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00411-008-0170-3","article-title":"Irradiation leads to apoptosis of Kupffer cells by a Hsp27-dependant pathway followed by release of TNF-alpha","volume":"47","author":"Tello","year":"2008","journal-title":"Radiat Environ Biophys"},{"key":"10.1016\/j.adro.2023.101367_bib0057","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0360-3016(99)00401-0","article-title":"Early alteration in TGF-beta mRNA expression in irradiated rat liver","volume":"46","author":"Seong","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101367_bib0058","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.ijrobp.2009.09.063","article-title":"Inactivation of kupffer cells by gadolinium chloride protects murine liver from radiation-induced apoptosis","volume":"76","author":"Du","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101367_bib0059","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/toxsci\/kfl173","article-title":"Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis","volume":"96","author":"Roberts","year":"2007","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.adro.2023.101367_bib0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00411-008-0200-1","article-title":"Irradiation leads to sensitization of hepatocytes to TNF-alpha-mediated apoptosis by upregulation of IkappaB expression","volume":"48","author":"Gurleyen","year":"2009","journal-title":"Radiat Environ Biophys"},{"issue":"Suppl(1)","key":"10.1016\/j.adro.2023.101367_bib0061","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2004.11.015","article-title":"Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD","volume":"42","author":"Durand","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.adro.2023.101367_bib0062","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/lt.23439","article-title":"Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation","volume":"18","author":"O'Connor","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.adro.2023.101367_bib0063","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/jso.22104","article-title":"Stereotactic body radiation therapy in hepatocellular carcinoma and cirrhosis: Evaluation of radiological and pathological response","volume":"105","author":"Facciuto","year":"2012","journal-title":"J Surg Oncol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109423001951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109423001951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:44:14Z","timestamp":1762530254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109423001951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2452109423001951"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2023.101367","relation":{},"ISSN":["2452-1094"],"issn-type":[{"type":"print","value":"2452-1094"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC) With Single Photon Emission Computed Tomography (SPECT) Functional Treatment Planning in Patients With Advanced Hepatic Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2023.101367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101367"}}